Savella
Product Images NDC 16590-845

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Savella (NDC 16590-845). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Savella 100mg Label Image (Savella 100mg Label 847)

SAVELLA 100 mg tablet label showing 60 tablets, labeled by STAT RX USA LLC. The label states it is a generic for milnacipran HCl with an NDC of 16590-847-60. Manufacturer is Forest Pharm, Inc., St. Louis, MO. Instructions include storing between 59-86 degrees and keeping out of reach of children. Additional warnings about alcohol use and medication effects are present.*

FDA Label Image

Savella 25mg Label Image (Savella 25mg Label 845)

SAVELLA 25 mg tablet bottle label showing 60 tablets, labeled for STAT RX USA LLC. The label includes the generic name Milnacipran HCl, an NDC number 16590-845-60, and manufacturing details by Forest Pharm, Inc. Dosage instructions refer to the package insert. The label also has warnings for RX only and to keep out of reach of children.*

FDA Label Image

Savella 50mg Label Image (Savella 50mg Label 846)

SAVELLA 50 mg tablets label shows a bottle containing 60 tablets. The label indicates it is a generic form containing Milnacipran HCl 50 mg per tablet. The product is packaged and distributed by STAT RX USA LLC, and manufactured by Forest Pharm., Inc., St. Louis, MO. The NDC number is 16590-846-60, with additional manufacturing and lot details.*

FDA Label Image

Structural Formula (Sav00 0004 01)

Chemical structure of the active ingredient in SAVELLA, showing a complex arrangement of carbon rings, an amine group, and a hydrochloride component, consistent with its molecular formula.*

FDA Label Image

Figure 1 (Sav00 0004 02)

A line graph showing percent improvement in pain from baseline on the x-axis and percent of patients improved on the y-axis. The graph compares three groups labeled Placebo, MLN 100mg, and MLN 200mg, with the placebo group showing lower improvement percentages than the two MLN dose groups.*

FDA Label Image

Figure 2 (Sav00 0004 03)

A line graph showing percent improvement in pain from baseline on the x-axis and percent of patients improved on the y-axis. It compares data between placebo and two dosages of MELN (100 mg and 200 mg) with respective lines in red, blue, and green.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.